Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysis

Hagit Kopel, Andre B. Araujo, Alina Bogdanov, Ni Zeng, Isabelle Winer, Jessamine Winer-Jones, Tianyi Lu, Morgan A. Marks, Mac Bonafede, Van Hung Nguyen, David Martin, James A. Mansi
doi: https://doi.org/10.1101/2024.04.10.24305549

Article usage

Article usage: April 2024 to January 2025

AbstractFullPdf
Apr 202480729300
May 202429918166
Jun 202430715161
Jul 202424914202
Aug 20241846129
Sep 20242366100
Oct 2024202564
Nov 20241992148
Dec 2024139171
Jan 202589567
Back to top
Posted April 12, 2024.
Download PDF
Data/Code
Email
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysis
Hagit Kopel, Andre B. Araujo, Alina Bogdanov, Ni Zeng, Isabelle Winer, Jessamine Winer-Jones, Tianyi Lu, Morgan A. Marks, Mac Bonafede, Van Hung Nguyen, David Martin, James A. Mansi
medRxiv 2024.04.10.24305549; doi: https://doi.org/10.1101/2024.04.10.24305549
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area